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CASE REPORT 
GIANT CELL TUMOUR OF THE SACRUM: FUNCTION-PRESERVING 
SURGERY WITH EXTENDED CURETTAGE AND ILIO-LUMBAR 
FUSION 
Riaz H. Lakdawala, Tashfeen Ahmad, Syed A. Enam,* 
Departments of Surgery and Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan 
Giant cell tumours of the sacrum pose a unique therapeutic challenge due to the inaccessibility of 
the tumour, significant intra-operative blood loss from extensive vascularity, high rate of local 
recurrence with conservative surgery, and loss of neurological function and mechanical instability 
with en-bloc excision. We present a case where successful outcome was achieved by tailoring 
treatment in consideration of the above issues. A 28 year old male diagnosed on biopsy to have 
giant cell tumour of the sacrum presented to us with low-back pain, left-sided S1 radiculopathy, 
ankle weakness and urinary incontinence. MRI showed a tumour involving the S1 and S2 
vertebral segments, breaching the posterior cortex and compressing the neural elements. An 
angiographic tumour embolization was performed followed by surgery through a posterior 
approach whereby an extended curettage was done, carefully freeing the sacral nerve roots and 
abrading the bone using high-speed burr. An ilio-sacro-lumbar fusion was done employing ilio-
lumbar instrumentation and bone grafting. Post-operatively, within a week the patient was 
ambulated with a lumbar corset. At 9 months follow-up, the patient was completely pain free, had 
no ankle weakness, and had normal continence. This treatment approach resulted in preservation 
of neurologic function and maintenance of spinal stability, thus the patient returned to full 
function. 
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INTRODUCTION 
Sacrum is the fourth most common site affected by giant 
cell tumour of bone and carries a 23% mortality rate.
1
 
There is no consensus regarding optimal management. 
Conventionally, giant cell tumours are treated surgically 
by curettage and bone grafting, but such intralesional 
excision results in 47% recurrence rate. Adjuvants such 
as electrocautery, phenol and bone cement are therefore 
used to reduce the risk of recurrence, but in the spine 
they pose a risk of injury to the neural elements. 
Moreover, difficulty in surgical treatment of giant cell 
tumours involving the sacrum also stem from the 
inaccessibility of the tumour, significant intra-operative 
blood loss due to extensive vascularity and post-
operative mechanical lumbo-sacro-pelvic instability. 
Thus, sacral giant cells tumours pose a unique 
therapeutic challenge and necessitate a modified 
management approach to preserve neurological and 
mechanical function. We present a case of giant cell 
tumour of the sacrum where successful outcome was 
achieved by tailoring treatment in consideration of these 
concepts. 
CASE 
The patient was a 28 year old male who was initially 
evaluated outside our hospital for symptoms of left-
sided S1 radiculopathy. An MRI was done (Figure-1) 
which showed a tumour involving the S1 and S2 
vertebral segments, breaching the posterior cortex and 
compressing the neural elements (Campanacci stage 
III).
2
 He underwent a left-S1 laminectomy and open 
biopsy in an outside hospital; the biopsy was reported as 
giant cell tumour. The patient continued to have pain 
and also developed urinary and bowel incontinence and 
ankle weakness, with which he presented to us. 
Examination revealed restricted straight leg raising test 
(R) 40°, (L) 30°, reduced sensation along S1, absent 
ankle jerks, absent perianal sensation and lax anal 
sphincter. CT scan showed tumour extending into the 
neural canal posteriorly from S1 and S2 sacral 
segments, and the previous left S1 laminectomy 
(Figure-2). MRI scan demonstrated local progression of 
the tumour as compared to the initial scan (Figure-3), 
approaching the sacro-iliac and lumbo-sacral joints. 
A preoperative angiography was performed, 
showing a tumour blush with feeding arteries coming 
from branches of the internal iliac arteries on both sides. 
Angiographic embolization of these tumour vessels was 
performed, with complete disappearance of the tumour 
blush (Figure-4). Subsequently, surgery was done 
through a posterior approach whereby an extended 
curettage was done. Blunt and sharp dissection was 
done to free the sacral nerve roots from the tumour, 
while the bone was abraded using high-speed burr. In 
order to prevent pistoning of the lumbar spine into the 
weakened sacrum, an ilio-lumbar instrumentation using 
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a construct of pedicle screws in the L4 and L5 vertebrae 
as well as both iliac crests, attached to contoured rods 
interconnected with a cross-link (Figure-5). Fibular and 
iliac bone grafting was done. Post-operatively, within a 
week the patient was ambulated with a lumbar corset. 
At 9 months follow-up, the patient was completely pain 
free, had no weakness of ankle plantar flexion (Figure-
6), and had normal bladder and bowel continence. 
DISCUSSION 
Although locally advanced giant cell tumours of the 
sacrum pose a difficult surgical challenge, our case 
illustrates a practical approach which has proven 
successful in eliminating the disease while preserving 
mechanical and neurological functions. In spinal tumours, 
non-operative treatment in the form of radiotherapy can 
be used as solitary treatment for inaccessible lesions, but 
there is up to 49% recurrence rate and a risk of late 
malignant transformation. There have been some recent 
developments in this modality, such as “megavoltage 
radiotherapy”. This entails administration of 30–70 gray 
over 5–7 weeks as the solitary treatment, and has been 
reported to give 85% non-progression of tumour at 10 
years.
3
 Angio-embolization has also been used as a 
solitary procedure, but is fraught with a 30% recurrence 
rate at 10 years and 43% at 20 years.
4,5
 However, when 
used pre-operatively, it significantly reduces intra-
operative bleeding and reduces surgical difficulty. Thus, 
surgical excision remains the mainstay of treatment of 
sacral giant cell tumours.
6,7
 Intra lesional curettage has 
been the gold standard for non-spinal lesions, but in the 
spine it is known to result in a high rate of local 
recurrence. The risk of local recurrence can only be 
eliminated by en bloc excision of the involved bone. 
However, en bloc excision is not the optimal treatment 
method in regions such as the sacrum because important 
neural elements lie within the bone. Moreover, if the 
neural canal is encroached upon by the tumour, during 
curettage it is not possible to use adjuvants because they 
would injure the nerves. Injury to S1 nerve roots results 
in loss of ankle plantar-flexion power required for 
normal gait, and injury to S2 nerve roots results in loss 
of bladder and bowel sphincter control. Thus, the use of 
intra-operative magnification and micro-dissection 
technique around the neural elements, and use of high 
speed burr and electrocautery in the margins help to 
reduce the residual tumour cells. En bloc excision as 
well as extensive intralesional curettage result in 
mechanical instability for which lumbo-sacro-pelvic 
reconstruction is recommended.
8
 In consideration of the 
above factors, we treated our patient with preoperative 
angio-embolization followed by surgery which entailed 
curettage and careful dissection to free the neural 
elements and use of high-speed burr on the margins of 




Figure-1: (A, B). Sagittal T-2 (A) and axial T-1 (B) weighted images from initial MRI scan showing expansile 
tumour (arrows) involving sacral segments S1 and S2 and bulging into the neural canal 
 
Figure-2: (A,B). CT scan images showing (A) Campanacci III lesion extending into the neural canal 
posteriorly from sacral segments S1 and S2 (arrow).  3-D reconstruction of sacrum viewed from behind (B) 
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Figure-3: (A, B) Images from MRI scan performed post-S1 laminectomy, sagittal (A) and axial (B) views, 
demonstrating tumour extension into the neural canal (arrows) adjacent S1 and S2 segment 
 
Figure-4: (A-D) Angiographic tumour embolization of lateral sacral arteries. (A, C) Pre-embolization images 
showing tumour blush (arrows) arising from branches from the left (A) and right (C) lateral sacral arteries. 
(B, D) Post-embolization images demonstrating disappearance of tumour blush (arrows) 
 
Figure-5: (A,B): (A) Per-operative AP and lateral X-rays showing iliolumbar instrumentation and bone 
grafting. (B) Follow-up X-rays performed nine months after surgery showing satisfactory fusion 
 
Figure-6: Clinical pictures showing preservation of lumbosacral contour and intact S1 function (toe-walk) 
A B 
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CONCLUSION 
The treatment method employed in our patient 
resulted in preservation of neurologic function and 
maintenance of lumbo-sacro-pelvic stability, thus the 
patient became symptom-free and returned to full 
function. A multi-modal therapeutic approach is 
warranted in the management of giant cell tumours of 
the sacrum. 
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